Incidental Mutation 'R6908:Lypd3'
ID 538861
Institutional Source Beutler Lab
Gene Symbol Lypd3
Ensembl Gene ENSMUSG00000057454
Gene Name Ly6/Plaur domain containing 3
Synonyms 2310061G07Rik, C4.4A
MMRRC Submission 045000-MU
Accession Numbers
Essential gene? Probably non essential (E-score: 0.188) question?
Stock # R6908 (G1)
Quality Score 225.009
Status Validated
Chromosome 7
Chromosomal Location 24335995-24340543 bp(+) (GRCm39)
Type of Mutation missense
DNA Base Change (assembly) G to C at 24337858 bp (GRCm39)
Zygosity Heterozygous
Amino Acid Change Glycine to Arginine at position 75 (G75R)
Ref Sequence ENSEMBL: ENSMUSP00000079543 (fasta)
Gene Model predicted gene model for transcript(s): [ENSMUST00000080718]
AlphaFold Q91YK8
Predicted Effect probably damaging
Transcript: ENSMUST00000080718
AA Change: G75R

PolyPhen 2 Score 1.000 (Sensitivity: 0.00; Specificity: 1.00)
SMART Domains Protein: ENSMUSP00000079543
Gene: ENSMUSG00000057454
AA Change: G75R

DomainStartEndE-ValueType
signal peptide 1 32 N/A INTRINSIC
LU 33 128 7.26e-26 SMART
Pfam:UPAR_LY6 142 224 1.3e-16 PFAM
low complexity region 234 255 N/A INTRINSIC
low complexity region 258 278 N/A INTRINSIC
low complexity region 303 320 N/A INTRINSIC
Coding Region Coverage
  • 1x: 100.0%
  • 3x: 99.9%
  • 10x: 99.4%
  • 20x: 98.2%
Validation Efficiency 95% (52/55)
MGI Phenotype PHENOTYPE: Homozygous null mice show no overt epidermal phenotype and have normal squamous epithelia morphology but are lighter and leaner than controls. Males display delayed wound healing whereas females show reduced food intake and a lower incidence of invasive lesions in a BBN-induced bladder cancer model. [provided by MGI curators]
Allele List at MGI
Other mutations in this stock
Total: 55 list
GeneRefVarChr/LocMutationPredicted EffectZygosity
Abi3bp T C 16: 56,477,668 (GRCm39) I1197T probably benign Het
Atp2a1 A G 7: 126,047,707 (GRCm39) probably null Het
B3glct T C 5: 149,619,941 (GRCm39) probably null Het
Bbs9 T G 9: 22,479,019 (GRCm39) I154S probably damaging Het
Brip1 T C 11: 85,968,710 (GRCm39) Y825C probably damaging Het
Ccdc186 A T 19: 56,780,371 (GRCm39) probably null Het
Celf6 T C 9: 59,511,106 (GRCm39) V349A probably benign Het
Chd9 A G 8: 91,683,044 (GRCm39) T495A probably benign Het
Cxxc1 G A 18: 74,353,630 (GRCm39) C546Y probably damaging Het
Cxxc5 T C 18: 35,992,268 (GRCm39) V223A probably damaging Het
Dlc1 A G 8: 37,404,841 (GRCm39) F316S probably benign Het
Dnajc12 C A 10: 63,233,104 (GRCm39) Q82K probably benign Het
Dock8 G A 19: 25,165,746 (GRCm39) E1877K probably damaging Het
Epha3 T G 16: 63,418,612 (GRCm39) H611P probably damaging Het
Fpr-rs6 C A 17: 20,402,701 (GRCm39) C220F probably damaging Het
Fryl A G 5: 73,179,554 (GRCm39) L2951P probably damaging Het
Gbp10 T G 5: 105,368,898 (GRCm39) T314P probably damaging Het
Hbb-bs T C 7: 103,476,741 (GRCm39) N77D probably benign Het
Ints13 A T 6: 146,456,531 (GRCm39) D438E probably damaging Het
Itgb6 C T 2: 60,480,365 (GRCm39) V324M probably benign Het
Kdm7a G T 6: 39,121,373 (GRCm39) L861M possibly damaging Het
Kirrel3 A G 9: 34,924,697 (GRCm39) T302A possibly damaging Het
Lama2 A T 10: 26,907,192 (GRCm39) probably null Het
Lrp2 A T 2: 69,302,709 (GRCm39) C3007S probably damaging Het
Mastl T C 2: 23,045,988 (GRCm39) probably benign Het
Mcf2l T C 8: 13,068,919 (GRCm39) V1087A probably benign Het
Mcmdc2 C A 1: 10,001,003 (GRCm39) probably null Het
Ms4a3 A G 19: 11,615,659 (GRCm39) I39T probably damaging Het
Mylk T G 16: 34,700,643 (GRCm39) C495G probably benign Het
Myo10 A G 15: 25,804,469 (GRCm39) D1588G probably damaging Het
Myo15a A T 11: 60,396,832 (GRCm39) T2634S probably damaging Het
Nlrp1b T C 11: 71,108,122 (GRCm39) I460V probably benign Het
Nmt1 T G 11: 102,949,080 (GRCm39) S312A possibly damaging Het
Nynrin T G 14: 56,101,335 (GRCm39) S335A probably benign Het
Or2d4 T C 7: 106,543,839 (GRCm39) Y123C possibly damaging Het
Paxip1 T C 5: 27,996,222 (GRCm39) Y19C possibly damaging Het
Pcdhb2 G T 18: 37,429,577 (GRCm39) A517S probably damaging Het
Pkd2l1 A G 19: 44,140,885 (GRCm39) I559T probably damaging Het
Plec G A 15: 76,070,081 (GRCm39) Q806* probably null Het
Prss51 C T 14: 64,333,601 (GRCm39) A70V probably benign Het
Psd3 A T 8: 68,416,829 (GRCm39) I356K probably benign Het
Ptprn2 A T 12: 116,852,508 (GRCm39) I522F probably benign Het
Rab39 T C 9: 53,617,369 (GRCm39) D16G probably damaging Het
Ralgps1 T C 2: 33,033,112 (GRCm39) Q439R probably benign Het
Rapgef2 A T 3: 79,011,370 (GRCm39) D238E probably benign Het
Ripor2 G A 13: 24,890,215 (GRCm39) G697S probably damaging Het
Scn11a A T 9: 119,621,492 (GRCm39) F642I probably damaging Het
Serinc4 G A 2: 121,284,086 (GRCm39) T310I probably benign Het
Sfpq GCCGCCGCAGCAGCCTCCGCCGCAGCAGCC GCCGCCGCAGCAGCC 4: 126,915,419 (GRCm39) probably benign Het
Slc36a3 T C 11: 55,040,712 (GRCm39) probably benign Het
Smc1b A G 15: 84,991,211 (GRCm39) S656P probably damaging Het
Sorbs1 A G 19: 40,340,776 (GRCm39) S455P probably damaging Het
Ttn C A 2: 76,720,202 (GRCm39) probably benign Het
Tyw5 T C 1: 57,440,682 (GRCm39) R27G probably damaging Het
Vmn1r209 T C 13: 22,990,400 (GRCm39) T97A possibly damaging Het
Other mutations in Lypd3
AlleleSourceChrCoordTypePredicted EffectPPH Score
IGL01129:Lypd3 APN 7 24,340,018 (GRCm39) missense probably benign 0.00
IGL01443:Lypd3 APN 7 24,336,063 (GRCm39) missense probably benign 0.03
R0200:Lypd3 UTSW 7 24,339,656 (GRCm39) missense probably damaging 1.00
R0726:Lypd3 UTSW 7 24,337,969 (GRCm39) nonsense probably null
R1706:Lypd3 UTSW 7 24,339,755 (GRCm39) missense probably benign 0.00
R5714:Lypd3 UTSW 7 24,338,494 (GRCm39) missense possibly damaging 0.86
R5771:Lypd3 UTSW 7 24,339,787 (GRCm39) missense probably benign
R6137:Lypd3 UTSW 7 24,339,919 (GRCm39) missense probably benign 0.00
R6932:Lypd3 UTSW 7 24,337,858 (GRCm39) missense probably damaging 1.00
R6935:Lypd3 UTSW 7 24,337,858 (GRCm39) missense probably damaging 1.00
R7632:Lypd3 UTSW 7 24,337,865 (GRCm39) missense possibly damaging 0.60
R8769:Lypd3 UTSW 7 24,337,932 (GRCm39) missense probably damaging 0.99
R9663:Lypd3 UTSW 7 24,338,349 (GRCm39) missense probably damaging 1.00
Predicted Primers PCR Primer
(F):5'- AGCCTGTTCTCGTTGGACTG -3'
(R):5'- GATGTCTGCAGTCTTCAACCC -3'

Sequencing Primer
(F):5'- GGACTGTATTCTTTGAAGCTCTTC -3'
(R):5'- TAGCTCCCAGCCCTAGTGTG -3'
Posted On 2018-11-06